Erev E. Tubb

590 total citations
5 papers, 506 citations indexed

About

Erev E. Tubb is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erev E. Tubb has authored 5 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erev E. Tubb's work include Colorectal Cancer Treatments and Studies (2 papers), T-cell and B-cell Immunology (2 papers) and Immunotherapy and Immune Responses (2 papers). Erev E. Tubb is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), T-cell and B-cell Immunology (2 papers) and Immunotherapy and Immune Responses (2 papers). Erev E. Tubb collaborates with scholars based in United States. Erev E. Tubb's co-authors include Eduardo M. Sotomayor, Ivan Borrello, Harold Bien, Hyam I. Levitsky, Zhengbin Lu, Stephen P. Schoenberger, Frédérique‐Marie Rattis, Hyam I. Levitsky, James P. Allison and Richard B. Sessions and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Erev E. Tubb

5 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erev E. Tubb United States	4	442	278	72	28	18	5	506
Theo Nicholaou Australia	5	357 0.8×	259 0.9×	107 1.5×	23 0.8×	19 1.1×	6	431
M. Hérin Belgium	6	418 0.9×	206 0.7×	141 2.0×	44 1.6×	22 1.2×	11	514
Heather Brouwer United Kingdom	6	350 0.8×	250 0.9×	83 1.2×	26 0.9×	8 0.4×	7	408
Ombretta Rosso Italy	8	307 0.7×	196 0.7×	100 1.4×	17 0.6×	21 1.2×	9	423
C. Huber Germany	6	305 0.7×	160 0.6×	148 2.1×	23 0.8×	28 1.6×	10	397
Mitsuko Ideno Japan	6	409 0.9×	341 1.2×	105 1.5×	24 0.9×	30 1.7×	9	479
Laura Fiammenghi Italy	9	286 0.6×	201 0.7×	123 1.7×	13 0.5×	15 0.8×	19	344
Mingxia Song Germany	8	254 0.6×	188 0.7×	167 2.3×	14 0.5×	21 1.2×	15	385
Juergen Kuball United States	3	281 0.6×	275 1.0×	65 0.9×	13 0.5×	22 1.2×	5	387
Sine Reker Denmark	9	277 0.6×	148 0.5×	169 2.3×	30 1.1×	23 1.3×	9	368

Countries citing papers authored by Erev E. Tubb

Since Specialization

Citations

This map shows the geographic impact of Erev E. Tubb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erev E. Tubb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erev E. Tubb more than expected).

Fields of papers citing papers by Erev E. Tubb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erev E. Tubb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erev E. Tubb. The network helps show where Erev E. Tubb may publish in the future.

Co-authorship network of co-authors of Erev E. Tubb

This figure shows the co-authorship network connecting the top 25 collaborators of Erev E. Tubb. A scholar is included among the top collaborators of Erev E. Tubb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erev E. Tubb. Erev E. Tubb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Tubb, Erev E., et al.. (2008). Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab). Journal of Clinical Oncology. 26(15_suppl). 15065–15065. 3 indexed citations

2.

Tubb, Erev E., Mark Jacobs, & Edith P. Mitchell. (2007). Response to the combination of cetuximab, bevacizumab and irinotecan (cetux/bev/iri) in patients (pts) previously treated with 3rd-line panitumumab, following disease progression on oxaliplatin, irinotecan and a fluoropyrimidine. Journal of Clinical Oncology. 25(18_suppl). 14586–14586. 1 indexed citations

3.

Sotomayor, Eduardo M., Ivan Borrello, Erev E. Tubb, et al.. (1999). Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nature Medicine. 5(7). 780–787. 348 indexed citations

4.

Sotomayor, Eduardo M., Ivan Borrello, Erev E. Tubb, James P. Allison, & Hyam I. Levitsky. (1999). In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proceedings of the National Academy of Sciences. 96(20). 11476–11481. 134 indexed citations

5.

Tubb, Erev E., et al.. (1993). Growth Factor mRNA Expression in Human Head and Neck Malignant Tumors. Archives of Otolaryngology - Head and Neck Surgery. 119(11). 1247–1252. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact